HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ryan Williams Selected Research

1- ((1- O- octadecyl- 2- O- methylglycero)phospho)- 3- deoxy- myo- inositol

10/2006The skin and hair as surrogate tissues for measuring the target effect of inhibitors of phosphoinositide-3-kinase signaling.
1/2004In vivo molecular pharmacology and antitumor activity of the targeted Akt inhibitor PX-316.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ryan Williams Research Topics

Disease

10Neoplasms (Cancer)
04/2015 - 01/2004
4Colonic Neoplasms (Colon Cancer)
04/2015 - 01/2004
3Hypoxia (Hypoxemia)
04/2009 - 03/2004
2Infections
08/2020 - 08/2014
2Carcinogenesis
10/2004 - 04/2003
1Hypertension (High Blood Pressure)
01/2022
1Obstructive Sleep Apnea
01/2022
1Wounds and Injuries (Trauma)
01/2022
1Substance-Related Disorders (Drug Abuse)
01/2021
1Pneumonia (Pneumonitis)
08/2020
1Nasal Obstruction
01/2019
1Femoracetabular Impingement
09/2015
1Pain (Aches)
09/2015
1Fatigue
01/2015
1Heart Failure
10/2014
1Abscess
08/2014
1Fistula
08/2014
1Intestinal Fistula
08/2014
1Peritoneal Neoplasms
08/2014
1Proctitis
08/2014
1Sepsis (Septicemia)
08/2014
1Malaria
01/2014
1Stroke (Strokes)
01/2012
1Eisenmenger Complex (Eisenmenger's Syndrome)
01/2012
1Pleural Effusion (Pleural Effusions)
09/2010
1Liver Failure
09/2010
1Cardiac Arrhythmias (Arrythmia)
09/2010
1Glioma (Gliomas)
04/2009
1Adenocarcinoma
04/2009
1Vascular Tissue Neoplasms
05/2005
1Papilloma (Papillomatosis)
10/2004
1Pancreatic Neoplasms (Pancreatic Cancer)
03/2004
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
03/2004
1Breast Neoplasms (Breast Cancer)
01/2004
1Hemolysis
01/2004

Drug/Important Bio-Agent (IBA)

3Pharmaceutical PreparationsIBA
01/2015 - 05/2005
32- amino- 3- (4'- N,N- bis(2- chloroethyl)amino)phenylpropionic acid N-oxideIBA
04/2009 - 03/2004
2Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2005
2Protein Kinases (Protein Kinase)IBA
04/2015 - 04/2003
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2009 - 03/2004
2Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA
10/2006 - 04/2003
21- ((1- O- octadecyl- 2- O- methylglycero)phospho)- 3- deoxy- myo- inositolIBA
10/2006 - 01/2004
2Transcription Factors (Transcription Factor)IBA
05/2005 - 03/2004
2Dihydrotachysterol (AT 10)IBA
07/2004 - 01/2004
1Peptide Hydrolases (Proteases)FDA Link
01/2022
1Acute-Phase Proteins (Acute-Phase Protein)IBA
01/2022
1IonsIBA
08/2020
1Pyrrolidinones (Pyrrolidones)IBA
08/2020
1SilverIBA
08/2020
1Hyaluronic Acid (Hyaluronan)IBA
09/2015
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2015
1Complementary DNA (cDNA)IBA
04/2015
1LigandsIBA
04/2015
1Peptides (Polypeptides)IBA
04/2015
1Antimalarials (Antimalarial Agents)IBA
01/2014
1Bosentan (Tracleer)FDA Link
01/2012
1Hypoxia-Inducible Factor 1IBA
03/2011
1Proteins (Proteins, Gene)FDA Link
04/2009
1Protein Isoforms (Isoforms)IBA
10/2006
1ParaffinIBA
06/2005
1PhosphoproteinsIBA
06/2005
1ThioredoxinsIBA
10/2004
1Acetic Acid (Vinegar)FDA LinkGeneric
07/2004
1PX-866IBA
07/2004
1EstersIBA
07/2004
1OxidesIBA
03/2004
1Glucose (Dextrose)FDA LinkGeneric
03/2004
1propionic acid (potassium propionate)IBA
03/2004
12-Hydroxypropyl-beta-cyclodextrinIBA
01/2004
1WortmanninIBA
01/2004

Therapy/Procedure

3Therapeutics
01/2021 - 01/2015
2Heart-Assist Devices
10/2014 - 01/2012
1Osteotomy
01/2022
1Precision Medicine
01/2022
1Mandibular Osteotomy
01/2022
1Palatal Expansion Technique
01/2019
1Nasal Surgical Procedures
01/2019
1Intra-Articular Injections
09/2015
1Injections
09/2015
1Colonic Pouches (S Pouch)
08/2014
1Radiotherapy
03/2011
1Electric Countershock (Cardioversion)
09/2010
1Liver Transplantation
09/2010
1Catheter Ablation
09/2010
1Aftercare (After-Treatment)
05/2005
1Intravenous Administration
01/2004